Literature DB >> 7735945

Gene alterations in intestinal metaplasia and gastric cancer.

E Tahara1, H Kuniyasu, W Yasui, H Yokozaki.   

Abstract

PURPOSE: To review genetic alterations in precancerous lesions and adenocarcinoma of the stomach.
RESULTS: Telomere reduction, tpr-met oncogenic rearrangement, overexpression of cripto, p53 mutations, adenomatous polyposis coli gene mutations and K-ras mutations, which are frequently associated with the well differentiated or intestinal type of stomach cancer, were found in intestinal metaplasia and adenoma of the stomach.
CONCLUSIONS: Among these genetic alterations, reduction of telomere repeat arrays might be the initial step in the genetic instability of stomach carcinogenesis. Some of the well differentiated type stomach cancers may develop by an accumulation of multiple gene changes similar to those of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7735945

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  15 in total

1.  Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers.

Authors:  T Hamamoto; H Yokozaki; S Semba; W Yasui; S Yunotani; K Miyazaki; E Tahara
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

2.  Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling.

Authors:  M Ishida; Y Gomyo; S Tatebe; S Ohfuji; H Ito
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  AKT plays a crucial role in gastric cancer.

Authors:  Takamitsu Sasaki; Yuichi Yamashita; Hiroki Kuniyasu
Journal:  Oncol Lett       Date:  2015-05-25       Impact factor: 2.967

4.  Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma.

Authors:  Robert Juvan; Petra Hudler; Barbara Gazvoda; Stanislav Repse; Matej Bracko; Radovan Komel
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

5.  Analysis of cell damage and proliferation in Helicobacter pylori-infected human gastric mucosa from patients with gastric adenocarcinoma.

Authors:  N Yabuki; H Sasano; M Tobita; A Imatani; T Hoshi; K Kato; S Ohara; S Asaki; T Toyota; H Nagura
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 6.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma.

Authors:  Lin Wang; Xiao-Ying Zhang; Ling Xu; Wen-Jun Liu; Juan Zhang; Jian-Ping Zhang
Journal:  Oncol Lett       Date:  2011-04-14       Impact factor: 2.967

Review 8.  Gastric cancer: pathogenesis, risks, and prevention.

Authors:  Pentti Sipponen
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 9.  Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect.

Authors:  A Schwarz
Journal:  Langenbecks Arch Surg       Date:  2003-02-19       Impact factor: 3.445

10.  Expression of mutant type-p53 products in H pylori-associated chronic gastritis.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Ryugo Sato; Koichiro Watanabe; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.